. 2024 Sep 12;23:297. doi: 10.1186/s12944-024-02270-2

Table 4.

Diagnostic performance of the CardioChek^® PA analyser

Capillary vs. Lab	Sensitivity (%) (95% CI)	Specificity (%) (95% CI)	Positive predictive value (PPV) (95% CI)	Negative predictive value (NPV) (95% CI)
Total cholesterol (TC)	60/105 57.1% (47.11–66.76)	83/88 94.3% (87.24–98.13)	60/65 92.3% (82.95–97.46)	83/128 64.8% (55.91–73.07)
Triglycerides (TG)	19/25 76.0% (54.87–90.64)	168/168 100.0% (97.83–100.0)	19/19 100.0% (82.35–100.0)	168/174 96.6% (92.65–98.72)
High-density lipoprotein (HDL) cholesterol	25/26 96.2% (80.36–99.90)	139/167 83.2% (76.7–88.6)	25/53 47.2% (33.30-61.36)	139/140 99.3% (96.08–99.98)
Low-density lipoprotein (LDL) cholesterol	111/137 81.0% (73.44–87.21)	56/56 100.0% (93.62–100.0)	111/111 100.0% (96.73–100.0)	56/82 68.3% (57.08–78.13)

Capillary vs. Lab

Sensitivity (%)
(95% CI)

Specificity (%)
(95% CI)

Positive predictive value (PPV)
(95% CI)

Negative predictive value (NPV)
(95% CI)

Total cholesterol (TC)

60/105

57.1%

(47.11–66.76)

83/88

94.3%

(87.24–98.13)

60/65

92.3%

(82.95–97.46)

83/128

64.8%

(55.91–73.07)

Triglycerides (TG)

19/25

76.0%

(54.87–90.64)

168/168

100.0%

(97.83–100.0)

19/19

100.0%

(82.35–100.0)

168/174

96.6%

(92.65–98.72)

High-density lipoprotein (HDL) cholesterol

25/26

96.2%

(80.36–99.90)

139/167

83.2%

(76.7–88.6)

25/53

47.2%

(33.30-61.36)

139/140

99.3%

(96.08–99.98)

Low-density lipoprotein (LDL) cholesterol

111/137

81.0%

(73.44–87.21)

56/56

100.0%

(93.62–100.0)

111/111

100.0%

(96.73–100.0)

56/82

68.3%

(57.08–78.13)